June 1, 2017
Related News
Other posts that you should not miss.
Positive early data from the BRIDGE1 study, a three-year 1000+ patient study in bronchiectasis funded by the …
June 3, 2019
ProAxsis will be presenting further data on its ProteaseTag® technology, at the North American Cystic Fibrosis Conference, …
October 30, 2017
ProAxsis is pleased to confirm that Professor Stephen Smith has become the Chairman of the company’s Board …
October 25, 2019
